Monocyte Chemoattractant Protein‐1 and Nitric Oxide Promote Adipogenesis in a Model That Mimics Obesity
暂无分享,去创建一个
E. Thompson | W. Morrison | A. Penington | K. Abberton | W. A. Morrison | K. Hemmrich | G. Thomas | J. Rophael
[1] K. Clément,et al. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. , 2007, Endocrinology.
[2] J. Kelly,et al. Contact with existing adipose tissue is inductive for adipogenesis in matrigel. , 2006, Tissue engineering.
[3] U. Smith,et al. Cytokines Promote Wnt Signaling and Inflammation and Impair the Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes* , 2006, Journal of Biological Chemistry.
[4] P. Reaven,et al. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. , 2006, Biochemical and biophysical research communications.
[5] D. Panagiotakos,et al. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. , 2005, Atherosclerosis.
[6] R. Busse,et al. Role of macrophage tissue infiltration in metabolic diseases , 2005, Current opinion in clinical nutrition and metabolic care.
[7] G. Stevens,et al. New Murine Model of Spontaneous Autologous Tissue Engineering, Combining an Arteriovenous Pedicle with Matrix Materials , 2004, Plastic and reconstructive surgery.
[8] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[9] H. Kotani,et al. Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice* , 2003, Journal of Biological Chemistry.
[10] B. Hedblad,et al. Inflammation-sensitive plasma proteins are associated with future weight gain. , 2003, Diabetes.
[11] R. Yu,et al. Macrophage inflammatory protein‐related protein‐2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation , 2003, FEBS letters.
[12] Christopher J. Lyon,et al. Minireview: adiposity, inflammation, and atherogenesis. , 2003, Endocrinology.
[13] P. Garcia-Lorda,et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. , 2003, Obesity research.
[14] G. Shillabeer,et al. Nitric oxide promotes differentiation of rat white preadipocytes in culture Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.M200305-JLR200 , 2002, Journal of Lipid Research.
[15] P. Newburger,et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. , 2002, Blood.
[16] I. Maridonneau-Parini,et al. Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively1 , 2002, The Journal of Immunology.
[17] S. Shyue,et al. NO Modulates Monocyte Chemotactic Protein-1 Expression in Endothelial Cells Under Cyclic Strain , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[18] G. Stevens,et al. The Influence of Extracellular Matrix on the Generation of Vascularized, Engineered, Transplantable Tissue , 2001, Annals of the New York Academy of Sciences.
[19] U. Das. Is obesity an inflammatory condition? , 2001, Nutrition.
[20] S. Haffner,et al. The relation of body fat mass and distribution to markers of chronic inflammation , 2001, International Journal of Obesity.
[21] A. Strosberg,et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes , 2001, Molecular and Cellular Endocrinology.
[22] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.
[23] P. Arner,et al. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. , 2000, Journal of lipid research.
[24] A. Aderem,et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.
[25] P. Arner,et al. A nitric oxide‐mediated mechanism regulates lipolysis in human adipose tissue in vivo , 1999, British journal of pharmacology.
[26] J A Frangos,et al. Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: role of NO, NF kappa B, and egr-1. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[27] Y. Giudicelli,et al. Modulation of White Adipose Tissue Lipolysis by Nitric Oxide* , 1998, The Journal of Biological Chemistry.
[28] A. Marette,et al. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. , 1998, American journal of physiology. Endocrinology and metabolism.
[29] M. Ross,et al. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. , 1996, Stroke.
[30] M. Ross,et al. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. , 1996, Stroke.
[31] S. James. Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.
[32] F. Fang,et al. NO inhibitions: antimicrobial properties of nitric oxide. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] G. Vassaux,et al. Proliferation and differentiation of rat adipose precursor cells in chemically defined medium: Differential action of anti‐adipogenic agents , 1994, Journal of cellular physiology.
[34] R. Sparks,et al. TGF‐β blocks early but not late differentiation‐specific gene expression and morphologic differentiation of 3T3 T proadipocytes , 1992, Journal of cellular physiology.
[35] R. L. Simmons,et al. Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.
[36] P. Lachmann,et al. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. , 1985, Journal of immunology.
[37] J. V. Fiore,et al. On the composition of zymosan. , 1958, Science.
[38] E. E. Ecker,et al. ANTICOMPLEMENTARY FACTOR IN FRESH YEAST , 1941 .